Welcome to Shanghai Medicilon, One of the Best CRO in China!
Medicilon is a leading CRO company that provides comprehensive drug R&D services on a global scale. From drug discovery, pharmaceutical research to preclinical research, Medicilon has supported more than 2000 client R&D programs worldwide resulting in 520+ IND filings. With proven scientific excellence and FDA-aligned methodologies, we help biotech and pharmaceutical innovators fast-track their path from discovery to IND success.
In addition, Medicilon offers attractive large animal models (non-human primates, dogs, rabbits, and miniature pigs), tumor & non-tumor animal models (including Xenograft models, PDX / PDXO models), and support for simultaneous China-U.S. IND filing to streamline global drug development and approval.
Medicilon leverages 20+ years of integrated preclinical expertise to accelerate drug discovery and development from target engagement through IND submission. With scalable chemistry, advanced biology platforms (AOCs, PROTACs, ADCs, CAR-T, mRNA display), and GLP- compliant pharmacology, DMPK, and toxicology, we provide seamless workflows to reduce development risk and timelines. This session highlights case studies and lessons from supporting global biotech and pharma programs.